Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
R Chowdhury, H Khan, E Heydon… - European heart …, 2013 - academic.oup.com
Aims The aim of this study was to determine the extent to which adherence to individual
vascular medications, assessed by different methods, influences the absolute and relative …
vascular medications, assessed by different methods, influences the absolute and relative …
Gender differences in the effects of cardiovascular drugs
An initiation-promotion protocol was used to test the hypothesis that unleaded gasoline (UG)
vapor acts as a liver tumor promoter in female mice under exposure conditions in which UG …
vapor acts as a liver tumor promoter in female mice under exposure conditions in which UG …
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial
JS Kutner, PJ Blatchford, DH Taylor… - JAMA internal …, 2015 - jamanetwork.com
Importance For patients with limited prognosis, some medication risks may outweigh the
benefits, particularly when benefits take years to accrue; statins are one example. Data are …
benefits, particularly when benefits take years to accrue; statins are one example. Data are …
American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of …
PS Jellinger, Y Handelsman, PD Rosenblit… - Endocrine Practice, 2017 - Elsevier
Objective The development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology …
Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology …
Statins for the primary prevention of cardiovascular disease
F Taylor, K Ward, THM Moore, M Burke… - Cochrane database …, 2011 - cochranelibrary.com
Background Reducing high blood cholesterol, a risk factor for cardiovascular disease (CVD)
events in people with and without a past history of coronary heart disease (CHD) is an …
events in people with and without a past history of coronary heart disease (CHD) is an …
Inflammaging as a target for healthy ageing
B Dugan, J Conway, NA Duggal - Age and Ageing, 2023 - academic.oup.com
Life expectancy has been on the rise for the past few decades, but healthy life expectancy
has not kept pace, leading to a global burden of age-associated disorders. Advancing age is …
has not kept pace, leading to a global burden of age-associated disorders. Advancing age is …
GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes
GRADE requires guideline developers to make an overall rating of confidence in estimates
of effect (quality of evidence—high, moderate, low, or very low) for each important or critical …
of effect (quality of evidence—high, moderate, low, or very low) for each important or critical …
How to use a subgroup analysis: users' guide to the medical literature
Clinicians, when trying to apply trial results to patient care, need to individualize patient care
and, potentially, manage patients based on results of subgroup analyses. Apparently …
and, potentially, manage patients based on results of subgroup analyses. Apparently …
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension …
Recommendations about therapy for hypertension are here preceded by some
considerations on the strength of available evidence on the benefits associated with …
considerations on the strength of available evidence on the benefits associated with …
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
BC Fellström, AG Jardine, RE Schmieder… - … England Journal of …, 2009 - Mass Medical Soc
Background Statins reduce the incidence of cardiovascular events in patients at high
cardiovascular risk. However, a benefit of statins in such patients who are undergoing …
cardiovascular risk. However, a benefit of statins in such patients who are undergoing …